Clinical Trial Update: A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 trial of Nimotuzumab with Pinkiller for advanced head and neck squamous cell carcinoma is ongoing. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)
• Pinkiller

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Head and Neck Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING